These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22282653)

  • 1. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.
    Gao D; Joshi N; Choi H; Ryu S; Hahn M; Catena R; Sadik H; Argani P; Wagner P; Vahdat LT; Port JL; Stiles B; Sukumar S; Altorki NK; Rafii S; Mittal V
    Cancer Res; 2012 Mar; 72(6):1384-94. PubMed ID: 22282653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis.
    Jian J; Pang Y; Yan HH; Min Y; Achyut BR; Hollander MC; Lin PC; Liang X; Yang L
    Oncotarget; 2017 Apr; 8(17):27725-27739. PubMed ID: 27223426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.
    Gao D; Vahdat LT; Wong S; Chang JC; Mittal V
    Cancer Res; 2012 Oct; 72(19):4883-9. PubMed ID: 23002209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
    Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
    Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
    Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
    Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premetastatic soil and prevention of breast cancer brain metastasis.
    Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
    Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.
    Said N; Sanchez-Carbayo M; Smith SC; Theodorescu D
    J Clin Invest; 2012 Apr; 122(4):1503-18. PubMed ID: 22406535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.
    Sceneay J; Chow MT; Chen A; Halse HM; Wong CS; Andrews DM; Sloan EK; Parker BS; Bowtell DD; Smyth MJ; Möller A
    Cancer Res; 2012 Aug; 72(16):3906-11. PubMed ID: 22751463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
    Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis.
    Asano K; Nelson CM; Nandadasa S; Aramaki-Hattori N; Lindner DJ; Alban T; Inagaki J; Ohtsuki T; Oohashi T; Apte SS; Hirohata S
    Sci Rep; 2017 Dec; 7(1):17225. PubMed ID: 29222454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
    Erler JT; Bennewith KL; Cox TR; Lang G; Bird D; Koong A; Le QT; Giaccia AJ
    Cancer Cell; 2009 Jan; 15(1):35-44. PubMed ID: 19111879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
    Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
    Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.
    Catena R; Bhattacharya N; El Rayes T; Wang S; Choi H; Gao D; Ryu S; Joshi N; Bielenberg D; Lee SB; Haukaas SA; Gravdal K; Halvorsen OJ; Akslen LA; Watnick RS; Mittal V
    Cancer Discov; 2013 May; 3(5):578-89. PubMed ID: 23633432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.
    Hebert JD; Myers SA; Naba A; Abbruzzese G; Lamar JM; Carr SA; Hynes RO
    Cancer Res; 2020 Apr; 80(7):1475-1485. PubMed ID: 32019869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting.
    Kischel P; Waltregny D; Dumont B; Turtoi A; Greffe Y; Kirsch S; De Pauw E; Castronovo V
    Int J Cancer; 2010 Feb; 126(3):640-50. PubMed ID: 19662655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.